Latest News in the pharma Industry

Research & Development

Achelios Therapeutics concludes successful Type C meeting with FDA regarding Topofen

Achelios Therapeutics concludes successful Type C meeting with FDA regarding Topofen

14 Jun 2017

Currently there are no approved topical NSAIDs indicated for the treatment of migraine.

Read more 
Lilly's galcanezumab significantly reduces number of migraine headache days

Lilly's galcanezumab significantly reduces number of migraine headache days

12 Jun 2017

New results presented at AHS.

Read more 
Lilly announces strategic collaboration with KeyBioscience

Lilly announces strategic collaboration with KeyBioscience

8 Jun 2017

Collaboration to focus on a potential new class of treatments for metabolic disorders.

Read more 
FDA Advisory Committee to review Avastin biosimilar candidate

FDA Advisory Committee to review Avastin biosimilar candidate

7 Jun 2017

The Committee will review analytical, pharmacokinetic and clinical data from studies involving ABP 215, including results from a Phase III study in patients with NSCLC.

Read more 
New BMS collaboration to evaluate combination therapy in colorectal cancer

New BMS collaboration to evaluate combination therapy in colorectal cancer

6 Jun 2017

Phase I/II study to evaluate the combination of Opdivo (nivolumab) and Opdivo +Yervoy (ipilimumab) regimen with Mekinist (trametinib) in patients with colorectal cancer.

Read more 
Combination therapy shown to shrink tumours in many patients whose cancer has spread to the brain

Combination therapy shown to shrink tumours in many patients whose cancer has spread to the brain

5 Jun 2017

Combination of nivolumab plus ipilimumab can fundamentally change survival expectations.

Read more 
Spinraza approved in the EU as first treatment for spinal muscular atrophy

Spinraza approved in the EU as first treatment for spinal muscular atrophy

2 Jun 2017

Robust data from Phase III studies demonstrated positive impact on motor milestone achievement; increased survival in infants with SMA.

Read more 
NICE approves first use of Opdivo in blood cancer

NICE approves first use of Opdivo in blood cancer

2 Jun 2017

NICE has recommended immunotherapy drug nivolumab for the treatment of adult patients with classical Hodgkin lymphoma.

Read more 
NIH researchers find potential genetic cause of Cushing syndrome

NIH researchers find potential genetic cause of Cushing syndrome

1 Jun 2017

Finding may lead to therapies that prevent pituitary tumor recurrence.

Read more 
Hookipa Biotech announces data showing TheraT turns cold tumours hot

Hookipa Biotech announces data showing TheraT turns cold tumours hot

30 May 2017

TheraT mediated alarmin release crucial for active immunization in cancer immunotherapy.

Read more 
FDA accepts for priority review BMS’s application for Opdivo in previously treated hepatocellular carcinoma

FDA accepts for priority review BMS’s application for Opdivo in previously treated hepatocellular carcinoma

26 May 2017

Application is based on results from the Phase I/II CheckMate -040 trial.

Read more 
Inovio HIV vaccine elicits nearly 100% immune response rates in a clinical study

Inovio HIV vaccine elicits nearly 100% immune response rates in a clinical study

26 May 2017

Amongst highest levels of immune responses ever demonstrated in an HIV vaccine human study.

Read more